dc.contributor.author | Hirschberg, Angelica Linden | |
dc.contributor.author | Bitzer, Johannes | |
dc.contributor.author | Cano, Antonio | |
dc.contributor.author | Ceausu, Iuliana | |
dc.contributor.author | Chedraui, Peter | |
dc.contributor.author | Durmuşoğlu, Fatih | |
dc.contributor.author | Erkkola, Risto | |
dc.contributor.author | Goulis, Dimitrios G. | |
dc.contributor.author | Kiesel, Ludwig | |
dc.contributor.author | Lopes, Patrice | |
dc.contributor.author | Pines, Amos | |
dc.contributor.author | van Trotsenburg, Mick | |
dc.contributor.author | Lambrinoudaki, Irene | |
dc.contributor.author | Rees, Margaret | |
dc.date.accessioned | 2021-06-17T08:49:21Z | |
dc.date.available | 2021-06-17T08:49:21Z | |
dc.date.issued | 2021 | en_US |
dc.identifier.citation | Hirschberg, A. L., Bitzer, J., Cano, A., Ceausu, I., Chedraui, P., Durmuşoğlu, F. ... Rees, M. (2021). Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide. Maturitas, 148, 55-61. https://dx.doi.org/10.1016/j.maturitas.2021.04.005 | en_US |
dc.identifier.issn | 0378-5122 | |
dc.identifier.issn | 1873-4111 | |
dc.identifier.uri | https://dx.doi.org/10.1016/j.maturitas.2021.04.005 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/7210 | |
dc.description.abstract | Introduction: Vulvovaginal atrophy (VVA) is a chronic condition caused by estrogen deficiency. It affects around 50% of postmenopausal women, reducing their general and sexual quality of life as well as the quality of their personal relationships. Aim: The aim of this clinical guide is to set out an individualized approach to the management of VVA with topical estrogens and non-hormonal preparations. Materials and methods: Literature review and consensus of expert opinion. Summary recommendations: An individualized approach is required for the management of VVA. Topical low-dose estrogens are effective and also alleviate urinary incontinence and prevent recurrent urinary tract infections. Women should not be denied long-term use of topical estrogens as long as they feel that this treatment is of benefit to them, because the safety data are reassuring. Non-hormonal preparations (lubricants and moisturizers) should be the first-line treatment for VVA in women taking adjuvant endocrine therapies for cancers considered to be hormone-dependent. They can be used over the long term. | en_US |
dc.description.sponsorship | Sistema de Investigacion y Desarrollo (SINDE) ; Vice-Rectorado de Investigacion & Postgrado (VRIP) of the Universidad Catolica de Santiago de Guayaquil, Guayaquil, Ecuador | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier Ireland Ltd | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Non-Hormonal Preparations | en_US |
dc.subject | Topical Estrogens | en_US |
dc.subject | Vulvovaginal Atrophy | en_US |
dc.title | Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide | en_US |
dc.type | article | en_US |
dc.relation.ispartof | Maturitas | en_US |
dc.department | İstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kadın Hastalıkları ve Doğum Ana Bilim Dalı | en_US |
dc.authorid | 0000-0003-4067-7887 | en_US |
dc.identifier.volume | 148 | en_US |
dc.identifier.startpage | 55 | en_US |
dc.identifier.endpage | 61 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.doi | 10.1016/j.maturitas.2021.04.005 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.identifier.scopusquality | Q1 | en_US |